palonosetron hydrochloride

Trials studying palonosetron hydrochloride

• phase1QLM2010 Comparative Pharmacokinetic Study With 2-Minute Intravenous Administrationnot yet recruitingn=42
• phase2A Clinical Trial of HRS5580 for Injection Combined With Palonosetron Hydrochloride for the Prevention of Postoperative Nausea and Vomitingnot yet recruitingn=260
• phase3APF530 or Aloxi (Palonosetron Hydrochloride) Combined With Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Cancercompletedn=1,428
• phase3To Evaluate the Efficacy and Safety of QLM2010 for Prevention of Chemotherapy-induced Nausea and Vomiting After Highly Emetogenic Chemotherapy.completedn=665
• phase2Buccal Film Versus IV Injection Palonosetron for Moderately Emetogenic Chemotherapy Induced Nausea and Vomitingcompletedn=22
• EP1An Relative Bioavailability Study of BH006 for Injection in Healthy Subjectsnot yet recruitingn=40
• phase3Clinical Study of HR20013 for Injection in Patients With Malignant Solid Tumorscompletedn=754
• phase3Netupitant and Palonosetron Hydrochloride in Preventing Chronic Nausea and Vomiting in Patients With Cancercompletedn=53